OKYO Pharma Operating Expenses Growth & History (OKYO)
OKYO Pharma's operating expenses was $8.5M for fiscal 2026.
View full OKYO Pharma company overviewOKYO Pharma annual operating expenses history
2020
2021
2022
2023
2024
2025
2026
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $8.5M | $3.7M | +75.70% |
| 2025 | 2025-03-31 | $4.8M | −$2.7M | −35.55% |
| 2024 | 2024-03-31 | $7.5M | $656,659 | +9.59% |
| 2023 | 2023-03-31 | $6.8M | $2.2M | +48.64% |
| 2022 | 2022-03-31 | $4.6M | $1.6M | +52.69% |
| 2021 | 2021-03-31 | $3.0M | $2.0M | +196.87% |
| 2020 | 2020-03-31 | $1.0M | — | — |
OKYO Pharma operating expenses trends
Over the last five fiscal years, OKYO Pharma's operating expenses increased from $3.0M to $8.5M, a change of $5.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OKYO Pharma source filings ↗